key: cord-0682627-05s8b0u2
authors: Zeilinger, Elisabeth L.; Lubowitzki, Simone; Unseld, Matthias; Schneckenreiter, Carmen; Heindl, Daniel; Staber, Philipp B.; Raderer, Markus; Valent, Peter; Zöchbauer‐Müller, Sabine; Bartsch, Rupert; Prager, Gerald; Jaeger, Ulrich; Gaiger, Alexander
title: The impact of COVID‐19 on cancer care of outpatients with low socioeconomic status
date: 2022-02-17
journal: Int J Cancer
DOI: 10.1002/ijc.33960
sha: b1097a1b28f9f9fcfd14aa9985c268566959dbaf
doc_id: 682627
cord_uid: 05s8b0u2

Patients with low socioeconomic status (SES) are among the most underserved groups of people regarding cancer care. Analyzing the impact of the coronavirus‐induced disease 2019 (COVID‐19) pandemic on health care disparities and calling attention to inequalities in cancer care is crucial to justify and initiate adequate countermeasures. We aimed to determine whether the COVID‐19 pandemic aggravated health care disparities of cancer outpatients related to their SES and analyzed patient data of the largest university center providing services for patients with hematologic and oncologic disorders in Austria from 2018 to 2021. SES was assessed using three indicators: monthly net household income, level of education and occupational prestige. In total, 1217 cancer outpatients (51.1% female) with a mean age of 59.4 years (SD = 14.2) participated. In the first year of the pandemic, the relative proportion of individuals with low income, low education level and low occupational prestige seeking cancer care at our outpatient center decreased significantly (P ≤ .015). The strongest indicator was income, with a consistent effect throughout the first pandemic year. Countermeasures and specific interventions to support cancer patients with low SES in their access to health care should be initiated and prioritized.

indicators: monthly net household income, level of education and occupational prestige. In total, 1217 cancer outpatients (51.1% female) with a mean age of 59.4 years (SD = 14.2) participated. In the first year of the pandemic, the relative proportion of individuals with low income, low education level and low occupational prestige seeking cancer care at our outpatient center decreased significantly (P ≤ .015). The strongest indicator was income, with a consistent effect throughout the first pandemic

year. Countermeasures and specific interventions to support cancer patients with low SES in their access to health care should be initiated and prioritized. What's new?

The COVID-19 pandemic caused disruptions to cancer care all over the world. But has it also worsened existing healthcare disparities for patients with low socioeconomic status? Here, using data from a European welfare state where patients have easy access to cancer treatment regardless of their employment or insurance status, the authors compared the socioeconomic status of cancer outpatients who received treatment before and during the pandemic. In the Abbreviations: COVID-19, coronavirus-induced disease 2019; SES, socioeconomic status.

first year of the pandemic, people with low socioeconomic status were seeking cancer care significantly less frequently than before the pandemic. Countermeasures to reach this underserved patient group are needed.

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses an unprecedented challenge on health care systems all over the world. Oncological care and screening were impacted as routine follow up visits and screenings were postponed or inpatients were switched to outpatient treatment. 1, 2 The influence of socioeconomic status (SES) on cancer care and survival of cancer patients is well established. 3 Important indicators for SES are income, education level and occupational prestige. 4 Oncology practitioners and researchers are apprehensive that the coronavirus-induced disease 2019 (COVID-19) situation has already exacerbated existing disparities in health care and will continue to do so. 5 A recent viewpoint reported on these health disparities in the United States and called for empirical data to support this view and provide a basis for national and international countermeasures. 6 In our study, we compared SES indicators of cancer outpatients being treated at the largest university center providing services for patients with oncologic and hematologic disorders in Austria before and during the pandemic to examine the impact of COVID-19 on disparities in access to cancer care. We present data from Austria, a European welfare state where patients have easy access to cancer treatment regardless of their employment or insurance status. Every patient with an oncologic or hematologic disorder can be seen in our center even without referral from a GP or specialist. Our data were collected at a university hospital where the most up-to-date cancer treatment options are offered and the highest standard of care is delivered. Cancer patients from all over the country seek treatment in this hospital, which contributes to the significance and representativeness of our data. Table 1 and did not differ significantly (P = .15).

We used three categories each for analyzing income (<1300 EUR/1300-2200 EUR) and education level (primary education/ secondary education/postsecondary or tertiary education); and two categories for occupational prestige (white collar workers, employees/ blue collar workers and unemployed people). We excluded retired persons for analyzing occupational prestige, as we had no information about their former employment status, leading to a reduced sample size of n = 573 for this analysis. Based on the assumption that income and education level were ordinally scaled, we used Mann-Whitney Utests and Kruskal-Wallis H-tests with post hoc Dunn tests. Bonferroni corrections for multiple tests were applied. Occupational prestige was analyzed as dichotomous variable with χ 2 tests. Cohen's d was used as effect size and interpretation followed Cohen's guidelines. 7 We analyzed three distinct time periods within the first year of the pandemic, based on the interventions and lockdowns that were in Table S1 .

In total, 1217 outpatients with cancer or other neoplastic conditions (51.1% female) participated, including 734 patients within 2 years prior to the COVID-19 pandemic, and 483 within the first year of the pandemic. Diagnoses of the sample are depicted in Table 2 . There were significantly more patients with a hematologic diagnosis in the sample during the pandemic than in the sample before the pandemic.

For all other cancer entities, no statistical significant differences in frequencies before and during the pandemic were found. Mean age of the total sample was 59.4 years (SD = 14.2). The 2 years prior to the COVID-19 pandemic were combined for all further analysis, representing the reference period before the pandemic. There were no statistically significant differences between these 2 years in income, level of education and occupational prestige. Table S2 . treatment and screening associated with low SES are exacerbated by the pandemic. 6, 8 In the present study, the changes in income level were consistent throughout the whole pandemic year and showed the largest effects of all three SES indicators in the total sample and in the subsample with a hematologic diagnosis. Education level did not differ in the first months of the pandemic but increased significantly during the second lockdown, indicating an alarming trend of fewer people with low SES receiving cancer treatment. Employment status showed comparable effect sizes, but did not reach statistical significance in the multigroup comparison in both in the total sample and the subsample with a hematologic diagnosis. This was presumably due to the reduced sample size for this analysis. It is worth noting that people living in Austria are provided with health insurance regardless of their employment. In countries where insurance coverage is highly dependent on employment status, this aspect may have a far more aggravating impact on health care. Furthermore, in low-and middle-income countries, cancer care for people with low SES may be even more affected by the COVID-19 pandemic than in high-income countries such as Austria or the United States. 9 People with low SES are generally more burdened by stressors and tend to underestimate the importance of cancer screening and cancer care. 10 The fear of a possible COVID-19 infection in the hospital may have outweighed the perceived benefit of cancer care. There are indications for general reductions in cancer screening and diagnoses, especially in countries were cancer screening services had been temporarily suspended like in the United Kingdom. 11 In Austria, cancer screening and health care services were never closed, but it may be that patients did not use these services for fear of COVID-19

infection. Recent studies indicate that people with low SES tend to have more fear of COVID-19, 12 and that an elevated fear of COVID-19 is linked to delays in care among patients with cancer. 13 The decline of people with low SES in our outpatient center may therefore also be associated with a decline in cancer screening and diagnosis in this population. This would also suggest that people with low SES are underutilizing health services during the pandemic compared to people with high SES.

Our outpatient center offers care with low-threshold access, and does not require a referral from a GP or specialist. However, during the first year of the pandemic, hospital access requirements (eg, mandatory face masks) were in place and often changed on short notice. In the early months of the pandemic, teleconsultations were increased to reduce face-to-face contacts. Aftercare visits that could be easily rescheduled without negative consequences for the patient were also postponed. These actions were not related to SES and are not expected to affect our results. Importantly, our outpatient center remained open to any patient seeking consultation or treatment.

We analyzed data from voluntary participants. Not every single patient visiting the oncology and hematology center was included, which can result in selection bias. However, there were no differences in response rates between time periods, indicating no specific bias.

Still, it could be that response patterns changed and people with low SES were less likely to participate in our study during the pandemic.

As discussed, people with low SES are generally more burdened by stressors. The stress of the pandemic could have led to a reduced response rate of people with low SES compared to people with higher SES.

Furthermore, our sample during the pandemic contained more patients with a hematologic diagnosis than the sample before the pandemic. This can be a potential bias and limits the generalizability of our results. Other cancer entities were equally distributed in the two samples. To tackle this potential bias, we examined the subsample of patients with a hematologic diagnosis, separately and confirmed the results found in the total sample. Furthermore, we did not assess stage of cancer or the necessity of treatment as these aspects are generally not SES-dependent.

Cancer outpatients with low SES were less frequently seen during the first year of the COVID-19 pandemic compared to the years before the pandemic. Despite having a significant impact on survival, this prognostic factor is currently neither integrated into routine care nor counteracted by specific programs addressing the needs of patients with low SES. The uptake of telemedicine and easily accessible medical support close to home could be promising strategies, 14 if designed as a low-threshold offer tailored to the needs of people with low SES. Furthermore, public health strategies, such as health education programs, should be enforced to communicate the importance of continuity of health care for chronic diseases such as cancer despite the presence of the pandemic. 

Carmen Schneckenreiter: Investigation, Data Curation, Writing-Review & Editing, Visualization. Daniel Heindl: Investigation, Data Curation, Writing-Review & Editing. Philipp B. Staber: Investigation, Writing-Review & Editing. Markus Raderer: Investigation, Writing-Review & Editing. Peter Valent: Investigation, Writing-Review & Editing. Sabine Zöchbauer-Müller: Investigation, Writing-Review & Editing. Rupert Bartsch: Investigation, Writing-Review & Editing. Gerald Prager: Investigation, Writing-Review &

Jaeger: Investigation, Writing-Review & Editing. Alexander Gaiger: Conceptualization, Methodology, Writing-Review & Editing, Supervision

Dramatic changes in oncology care pathways during the COVID-19 pandemic: the French ONCOCARE-COV study

McGill Task Force on the Impact of COVID-19 on Cancer Control and Care. Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada

The impact of socioeconomic position on non-communicable diseases: what do we know about it?

A glossary for social epidemiology

Cancer disparities in the COVID-19 era

Disparities in cancer outcomes due to COVID-19-a tale of 2 cities

Statistical Power Analysis for the Behavioral Sciences

Socioeconomic and racial inequities in breast cancer screening during the COVID-19 pandemic in Washington state

Dual challenge of cancer and COVID-19: impact on health care and socioeconomic systems in Asia Pacific

Psychosocial determinants of socioeconomic inequalities in cancer screening participation: a conceptual framework

The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study

Factors explaining the fear of being infected with COVID-19. Health Expect

Examining the association among fear of COVID-19, psychological distress, and delays in cancer care

Disparities in the uptake of telemedicine during the COVID-19 surge in a multidisciplinary head and neck cancer population by patient demographic characteristics and socioeconomic status

The data that support the findings of our study are available from the corresponding author upon reasonable request.

The study was approved by the institutional ethics committee of the